Larry Robbins bought $4.7M of Butterfly Network (BFLY)
Executed Dec 3 2025, disclosed Dec 5 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Dec 5 2025), the stock returned +32.2% (delay-adjusted); from the execution session (Dec 3 2025), +36.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
Larry Robbins (Director) filed 5 Form 4 reports in the trailing twelve months (2 purchases, 3 sales), most often in Butterfly Network, Inc. (BFLY). Across 2 priced purchase filings, the average 21-session return was +54.0% from execution and +46.3% from disclosure (delay-adjusted; derived). The largest single filing was $317.4M of CVS (3,371,049 sh across 5 lots, as filed), executed May 19.
Healthcare · Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→2,297,733 sh across 5 lots
Exec Aug 13
Filed Aug 17 · 7:01 PM ET BFLYSALE Butterfly Network, Inc. $14.0M
1,876,292 sh across 2 lots
Exec Jul 31
Filed Aug 3 · 6:11 PM ET BFLYPURCHASE Butterfly Network, Inc. $6.8M
2,800,000 sh across 3 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:35 PM ET